Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2005
07/12/2005US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use
07/12/2005CA2349142C Compositions and methods for stimulating gastrointestinal motility
07/12/2005CA2094494C A 4-quinolone antibiotic compound as gamma ray scintigraphy diagnostic imaging agent
07/07/2005WO2005061519A1 Kinase inhibitors
07/07/2005WO2005061513A1 Polycyclic agents for the treatment of respiratory syncytial virus infections
07/07/2005WO2005061512A1 Spiro-condensed indoline derivates as pesticides
07/07/2005WO2005061500A1 Spiropiperidine derivatives for controlling pests
07/07/2005WO2005061498A1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
07/07/2005WO2005061497A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
07/07/2005WO2005061496A1 Aminopyridine-derivatives as inductible no-synthase inhibitors
07/07/2005WO2005061475A2 Ornithine derivatives as prostaglandin e2 agonists or antagonists
07/07/2005WO2005061466A1 Novel phenylalanine derivative
07/07/2005WO2005061460A1 Compounds, compositions, and methods
07/07/2005WO2005061450A2 Hiv protease inhibiting sulfonamides
07/07/2005WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005WO2005060959A1 Pyrazole derivatives and use thereof as orexin receptor antagonists
07/07/2005WO2005060571A2 Antiprotozoal imidazopyridine compounds
07/07/2005WO2005047258A3 Methods and compositions for selectin inhibition
07/07/2005WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
07/07/2005WO2005037783A3 Use of tricyclic compounds as glycine transport inhibitors
07/07/2005WO2005037052A3 Binding assay with labelled bispidine variant
07/07/2005WO2005034869A3 Compounds and compositions as protein kinase inhibitors
07/07/2005WO2005023808A3 Process for the preparation of renzapride and intermediates thereof
07/07/2005WO2004058704A3 Quinazolinones as potassium channel modulators
07/07/2005US20050148769 Tricyclic compound having spiro union
07/07/2005US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals
07/07/2005US20050148623 HIV protease inhibiting compounds
07/07/2005US20050148622 Process for preparing acid salts of gemifloxacin
07/07/2005US20050148620 Administering N-(2-{2-[4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl]ethoxy}ethyl)methanesulfonamide as immune response modifier for treating viral and neoplastic diseases
07/07/2005US20050148619 Sulfonamido ether substituted imidazoquinolines
07/07/2005US20050148618 Tricyclic n-acyl compounds
07/07/2005US20050148617 Drugs for eating disorders and treating obesity or anxiety with G protein
07/07/2005US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/07/2005US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs
07/07/2005US20050148603 Compositions useful as inhibitors of protein kinases
07/07/2005US20050148602 Inhibitors of alphaLbeta2 mediated cell adhesion
07/07/2005US20050148593 Compounds, compositions, and methods
07/07/2005US20050148592 Use of riboflavin and flavin derivatives as chitinase inhibitors
07/07/2005US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof
07/07/2005US20050148586 Quinoxalinones
07/07/2005US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome
07/07/2005US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance
07/07/2005US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury
07/07/2005US20050148573 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
07/07/2005DE10357510A1 Heteroarylsubstituierte Benzole Heteroaryl-substituted benzenes
07/07/2005DE10356579A1 Aminderivate Amine derivatives
07/07/2005CA2792483A1 Hiv protease inhibiting sulfonamides
07/07/2005CA2550958A1 Ornithine derivatives as prostaglandin e2 agonists or antagonists
07/07/2005CA2550843A1 Novel phenylalanine derivatives
07/07/2005CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005CA2549510A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
07/07/2005CA2549389A1 Hiv protease inhibiting sulfonamides
07/07/2005CA2549183A1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
07/07/2005CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
07/07/2005CA2547814A1 Spiropiperidine derivatives for controlling pests
07/07/2005CA2540230A1 Aminopyridine-derivatives as inductible no-synthase inhibitors
07/06/2005EP1549652A1 Fused azole-pyrimidine derivatives
07/06/2005EP1549650A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines
07/06/2005EP1549649A1 Process for preparing haloalkyl pyrimidines
07/06/2005EP1549648A1 Bicyclic heteroaromatic compounds as kinase inhibitors
07/06/2005EP1549647A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines
07/06/2005EP1549646A2 Piperidine derivatives
07/06/2005EP1549637A1 1- (indol-3-yl)carbonyl piperazine derivatives
07/06/2005EP1549635A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
07/06/2005EP1549634A1 Novel substituted indoles
07/06/2005EP1549620A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors
07/06/2005EP1549614A2 Vasculostatic agents and methods of use thereof
07/06/2005EP1549315A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
07/06/2005EP1549313A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
07/06/2005EP1549309A2 Somatostatin analogue compounds
07/06/2005EP1487833B1 Process for preparing a pharmaceutically active compound (granisetron)
07/06/2005EP1077979B1 Method for producing (s,s)-benzyl-2,8-diazabicyclo 4.3.0]nonane
07/06/2005EP1044001B1 Integrin receptor antagonists
07/06/2005CN1636005A Benzothiazinone and benzoxazinone compounds
07/06/2005CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
07/06/2005CN1634894A Spiro[benzocyclo-4'-piperidine-2'-one] template compound and method for preparing same
07/06/2005CN1209363C Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same
07/05/2005US6914066 1,2-annelated quinoline derivatives
07/05/2005US6914052 Dideoxynucleoside analog compounds containing a dideoxy ribofuranosyl moiety that exhibit selective anti-viral activity coupled with substantially low toxicity toward host cells; treatment of HIV
07/05/2005CA2220509C Fused polycyclic heterocycle derivatives
07/05/2005CA2072541C Heterocyclic compounds, their production and use
06/2005
06/30/2005WO2005058913A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents
06/30/2005WO2005058909A2 Method of preparing porphyrin derivatives, porphyrin derivatives, uses thereof and pharmaceutical compositions
06/30/2005WO2005058897A1 Spiroindoline derivatives having insecticidal properties
06/30/2005WO2005058896A2 Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate
06/30/2005WO2005058895A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt.
06/30/2005WO2005058894A1 Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
06/30/2005WO2005058893A1 Tricyclic benzimidazoles
06/30/2005WO2005058892A1 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
06/30/2005WO2005058891A1 Pyrrolopyridine-substituted benzol derivatives for treating cardiovascular diseases
06/30/2005WO2005058890A2 Hydronopol derivatives as agonists on human orl1 receptors
06/30/2005WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics
06/30/2005WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use
06/30/2005WO2005058841A2 Hiv protease inhibiting compounds
06/30/2005WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists
06/30/2005WO2005058327A1 Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists
06/30/2005WO2005058317A1 Glycine transporter-1 inhibirors
06/30/2005WO2005039589A3 Cftr channel modulators
06/30/2005WO2005035533A8 Modulators of serotonin receptors